Filippo Mazzoni
Datos Biográficos
| ID | 7685485 |
|---|---|
| NOMBRE | Filippo Mazzoni |
| NOMBRES | Filippo |
| APELLIDO | Mazzoni |
| FIRMA | MAZZONI F |
| AFILIACIONES | University of Pavia |
| ORCID | 0000-0002-4114-6829 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2024 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Personalizing esketamine treatment in TRD and TRBD
These findings highlight the importance of a personalized treatment approach in treatment- resistant depressive episode patients. Esketamine may be particularly beneficial in reducing cognitive rigidity, improving mentalization, and breaking the cognitive inflexibility that contributes to sustained negative depressive thinking patterns. Further research is needed to refine patient stratification and optimize treatment strategies for individuals w…
Risk factors for suicidal attempts in a sample of outpatients with treatment-resistant depression
The integrated treatment of comorbidities and substance abuse, which involves different mental health services, is fundamental in achieving the recovery of these patients. Our study supports the importance of performing a careful clinical evaluation of patients with TRD in order to identify factors associated with increased risk of suicide attempts
Sin obras prominentes en esta página.
Risk factors for suicidal attempts in a sample of outpatients with treatment-resistant depression
The integrated treatment of comorbidities and substance abuse, which involves different mental health services, is fundamental in achieving the recovery of these patients. Our study supports the importance of performing a careful clinical evaluation of patients with TRD in order to identify factors associated with increased risk of suicide attempts
Personalizing esketamine treatment in TRD and TRBD
These findings highlight the importance of a personalized treatment approach in treatment- resistant depressive episode patients. Esketamine may be particularly beneficial in reducing cognitive rigidity, improving mentalization, and breaking the cognitive inflexibility that contributes to sustained negative depressive thinking patterns. Further research is needed to refine patient stratification and optimize treatment strategies for individuals w…
Depression (economics (2 obras) · Major depressive disorder (2 obras) · Treatment of Major Depression (2 obras) · Antidepressant (1 obras) · Anxiety (1 obras) · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 obras) · Cognition (1 obras) · Cognitive bias (1 obras) · Comorbidity (1 obras) · Depressive symptoms (1 obras)